0 XP   0   0   0

Nexgel Inc
Buy, Hold or Sell?

Should you buy, hold or sell Nexgel?

I guess you are interested in Nexgel Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Nexgel

Let's start. I'm going to help you getting a better view of Nexgel Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Nexgel Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Nexgel Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Nexgel Inc. The closing price on 2023-01-31 was $1.41 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Nexgel Inc Daily Candlestick Chart
Nexgel Inc Daily Candlestick Chart
Summary









1. Valuation of Nexgel




Current price per share

$1.41

2. Growth of Nexgel




Is Nexgel growing?

Current yearPrevious yearGrowGrow %
How rich?$8.2m$638.7k$9.3m93.6%

How much money is Nexgel making?

Current yearPrevious yearGrowGrow %
Making money-$1.4m-$838.2k-$596k-41.6%
Net Profit Margin-292.9%-369.2%--

How much money comes from the company's main activities?

3. Financial Health of Nexgel




Comparing to competitors in the Medical Instruments & Supplies industry




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#168 / 188

Most Revenue
#169 / 188

Most Profit
#130 / 188

Most Efficient
#167 / 188


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Nexgel Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Nexgel earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Nexgel to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of -216.0% means that $-2.16 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Nexgel Inc:

  • The MRQ is -216.0%. The company is making a huge loss. -2
  • The TTM is -292.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-216.0%TTM-292.9%+76.9%
TTM-292.9%YOY-369.2%+76.3%
TTM-292.9%5Y-314.3%+21.4%
5Y-314.3%10Y-314.3%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-216.0%7.5%-223.5%
TTM-292.9%7.3%-300.2%
YOY-369.2%8.7%-377.9%
5Y-314.3%6.8%-321.1%
10Y-314.3%7.0%-321.3%
1.1.2. Return on Assets

Shows how efficient Nexgel is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Nexgel to the Medical Instruments & Supplies industry mean.
  • -10.9% Return on Assets means that Nexgel generated $-0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Nexgel Inc:

  • The MRQ is -10.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -10.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-10.9%TTM-10.3%-0.6%
TTM-10.3%YOY-24.5%+14.2%
TTM-10.3%5Y-30.3%+20.0%
5Y-30.3%10Y-30.3%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.9%1.5%-12.4%
TTM-10.3%1.4%-11.7%
YOY-24.5%1.5%-26.0%
5Y-30.3%1.2%-31.5%
10Y-30.3%1.3%-31.6%
1.1.3. Return on Equity

Shows how efficient Nexgel is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Nexgel to the Medical Instruments & Supplies industry mean.
  • -14.9% Return on Equity means Nexgel generated $-0.15 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Nexgel Inc:

  • The MRQ is -14.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -14.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.9%TTM-14.3%-0.6%
TTM-14.3%YOY-337.0%+322.7%
TTM-14.3%5Y-136.1%+121.7%
5Y-136.1%10Y-136.1%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.9%2.4%-17.3%
TTM-14.3%2.6%-16.9%
YOY-337.0%2.9%-339.9%
5Y-136.1%2.3%-138.4%
10Y-136.1%2.4%-138.5%

1.2. Operating Efficiency of Nexgel Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Nexgel is operating .

  • Measures how much profit Nexgel makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Nexgel to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of -173.4% means the company generated $-1.73  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Nexgel Inc:

  • The MRQ is -173.4%. The company is operating very inefficient. -2
  • The TTM is -178.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-173.4%TTM-178.6%+5.2%
TTM-178.6%YOY-296.5%+117.9%
TTM-178.6%5Y-270.0%+91.4%
5Y-270.0%10Y-270.0%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-173.4%10.1%-183.5%
TTM-178.6%9.8%-188.4%
YOY-296.5%10.8%-307.3%
5Y-270.0%7.9%-277.9%
10Y-270.0%7.2%-277.2%
1.2.2. Operating Ratio

Measures how efficient Nexgel is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 2.83 means that the operating costs are $2.83 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Nexgel Inc:

  • The MRQ is 2.826. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.705. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.826TTM2.705+0.121
TTM2.705YOY4.195-1.489
TTM2.7055Y3.798-1.093
5Y3.79810Y3.7980.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8261.172+1.654
TTM2.7051.094+1.611
YOY4.1950.990+3.205
5Y3.7981.046+2.752
10Y3.7981.006+2.792

1.3. Liquidity of Nexgel Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Nexgel is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 7.46 means the company has $7.46 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Nexgel Inc:

  • The MRQ is 7.457. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.690. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.457TTM5.690+1.767
TTM5.690YOY0.611+5.080
TTM5.6905Y1.833+3.857
5Y1.83310Y1.8330.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ7.4572.529+4.928
TTM5.6902.586+3.104
YOY0.6112.402-1.791
5Y1.8332.490-0.657
10Y1.8332.359-0.526
1.3.2. Quick Ratio

Measures if Nexgel is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Nexgel to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 12.25 means the company can pay off $12.25 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Nexgel Inc:

  • The MRQ is 12.253. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 7.265. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ12.253TTM7.265+4.988
TTM7.265YOY0.383+6.882
TTM7.2655Y1.957+5.308
5Y1.95710Y1.9570.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ12.2531.102+11.151
TTM7.2651.064+6.201
YOY0.3831.119-0.736
5Y1.9571.094+0.863
10Y1.9571.026+0.931

1.4. Solvency of Nexgel Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Nexgel assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Nexgel to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.27 means that Nexgel assets are financed with 26.8% credit (debt) and the remaining percentage (100% - 26.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Nexgel Inc:

  • The MRQ is 0.268. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.287. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.268TTM0.287-0.018
TTM0.287YOY0.822-0.535
TTM0.2875Y0.634-0.347
5Y0.63410Y0.6340.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2680.347-0.079
TTM0.2870.341-0.054
YOY0.8220.368+0.454
5Y0.6340.376+0.258
10Y0.6340.372+0.262
1.4.2. Debt to Equity Ratio

Measures if Nexgel is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Nexgel to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 36.7% means that company has $0.37 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Nexgel Inc:

  • The MRQ is 0.367. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.403. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.367TTM0.403-0.036
TTM0.403YOY11.212-10.809
TTM0.4035Y4.146-3.743
5Y4.14610Y4.1460.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3670.517-0.150
TTM0.4030.520-0.117
YOY11.2120.591+10.621
5Y4.1460.628+3.518
10Y4.1460.632+3.514

2. Market Valuation of Nexgel Inc

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Nexgel generates.

  • Above 15 is considered overpriced but always compare Nexgel to the Medical Instruments & Supplies industry mean.
  • A PE ratio of -6.86 means the investor is paying $-6.86 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Nexgel Inc:

  • The EOD is -6.403. Company is losing money. -2
  • The MRQ is -6.857. Company is losing money. -2
  • The TTM is -7.685. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-6.403MRQ-6.857+0.454
MRQ-6.857TTM-7.685+0.828
TTM-7.685YOY--7.685
TTM-7.6855Y-1.808-5.877
5Y-1.80810Y-1.8080.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-6.40359.546-65.949
MRQ-6.85761.746-68.603
TTM-7.68585.285-92.970
YOY-98.197-98.197
5Y-1.80857.263-59.071
10Y-1.80853.213-55.021
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Nexgel.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Nexgel Inc:

  • The MRQ is -8.419. Very Bad. -2
  • The TTM is -9.290. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-8.419TTM-9.290+0.871
TTM-9.2905Y-9.2900.000
5Y-9.29010Y-9.2900.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.419-0.016-8.403
TTM-9.290-0.191-9.099
5Y-9.2900.044-9.334
10Y-9.2900.101-9.391

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Nexgel is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 1.02 means the investor is paying $1.02 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Nexgel Inc:

  • The EOD is 0.956. Very good. +2
  • The MRQ is 1.024. Good. +1
  • The TTM is 1.071. Good. +1
Trends
Current periodCompared to+/- 
EOD0.956MRQ1.024-0.068
MRQ1.024TTM1.071-0.047
TTM1.071YOY-+1.071
TTM1.0715Y0.252+0.819
5Y0.25210Y0.2520.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD0.9562.751-1.795
MRQ1.0242.850-1.826
TTM1.0713.702-2.631
YOY-4.453-4.453
5Y0.2523.597-3.345
10Y0.2523.186-2.934
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Nexgel Inc.

3.1. Institutions holding Nexgel Inc

Institutions are holding 1.933% of the shares of Nexgel Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-09-30Massey, Quick & Co. LLC0.64090.00763571500
2022-09-30Renaissance Technologies Corp0.37380208316002.9657
2022-09-30Morgan Stanley - Brokerage Accounts0.285301590000
2022-09-30Two Sigma Advisers, LLC0.23240.000112950-900-6.4982
2022-09-30UBS Group AG0.180100307692328.9991
2022-09-30Tower Research Capital LLC0.12150.0002676864632119.0164
2022-09-30Tekla Capital Management LLC0.07610.0003424300
2022-09-30Wells Fargo & Co0.00050301376.4706
2022-09-30Retirement Group, LLC0.00010300
2022-09-30Credit Suisse First Boston (CSFB)00200
2022-06-30Citadel Advisors Llc000-10959-100
Total 1.91060.0082106472+2909+2.7%

3.2. Funds holding Nexgel Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-06-30Tekla Healthcare Investors0.05330.0006297000
2022-06-30Tekla Life Sciences Investors0.02280.0006127300
2022-11-30Fidelity® NASDAQ Composite Index®0.0098054700
2022-09-30Blackstone Alternative Multi-Strategy I0.0054030000
2022-11-30Fidelity® Extended Market Index0.0032017900
2022-11-30DFA US Small Cap I0.0027015200
2022-12-31NT Ext Equity Mkt Idx Fd - L0.00105800
2022-09-30Northern Trust Extended Eq Market Idx0.001058551833.3333
2022-11-30DFA US Micro Cap I0.000804300
2022-12-31NT Ext Equity Mkt Idx Fd - NL0.000402200
2022-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.000301800
2022-09-30Northern Trust Wilshire 50000.0002010100
2022-12-31NT US Market Cap Idx Fd - L0.000201000
2022-11-30Spartan Extended Market Index Pool E0.00010500
Total 0.10120.00125645+65+1.2%

3.3. Insider Transactions

Insiders are holding 23.337% of the shares of Nexgel Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-12-19David StefanskyBUY50001.5940091
2022-12-12David StefanskyBUY75001.4435091
2022-11-29Nachum SteinBUY30001.67487458
2022-11-25Nachum SteinBUY20001.2484458
2022-11-23Nachum SteinBUY1001.2483458
2022-11-21Nachum SteinBUY20001.17483358
2022-08-30David StefanskyBUY50001.6627591
2022-08-25David StefanskyBUY50001.7322591
2022-08-15David StefanskyBUY28721.915091
2022-06-24David StefanskyBUY31281.612219
2022-05-31Adam E Drapczuk IiiBUY50001.5420000
2022-05-27Adam E Drapczuk IiiBUY150001.6315000
2022-03-25Adam R LevyBUY12501.89
2022-03-25Nachum SteinBUY50001.9

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Nexgel Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.2030.347-158%0.005-4209%0.087-334%0.087-334%
Book Value Growth--0.8796.902-87%3.940-78%3.458-75%3.458-75%
Book Value Per Share--1.4751.793-18%0.115+1187%0.483+205%0.483+205%
Book Value Per Share Growth--0.8796.902-87%3.940-78%3.458-75%3.458-75%
Current Ratio--7.4575.690+31%0.611+1121%1.833+307%1.833+307%
Debt To Asset Ratio--0.2680.287-6%0.822-67%0.634-58%0.634-58%
Debt To Equity Ratio--0.3670.403-9%11.212-97%4.146-91%4.146-91%
Dividend Per Share----0%-0%-0%-0%
Eps---0.220-0.257+17%-0.150-32%-0.146-34%-0.146-34%
Eps Growth--0.8140.924-12%--0.924-12%0.924-12%
Free Cash Flow Per Share---0.162-0.157-3%-0.113-30%-0.103-37%-0.103-37%
Free Cash Flow Per Share Growth--0.7590.859-12%0.914-17%0.370+105%0.370+105%
Free Cash Flow To Equity Per Share---0.4280.210-304%0.117-464%0.077-657%0.077-657%
Free Cash Flow To Equity Per Share Growth--0.9203.940-77%3.128-71%2.109-56%2.109-56%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--5.138--------
Intrinsic Value_10Y_min---2.000--------
Intrinsic Value_1Y_max---0.327--------
Intrinsic Value_1Y_min---0.560--------
Intrinsic Value_3Y_max---0.340--------
Intrinsic Value_3Y_min---1.381--------
Intrinsic Value_5Y_max--0.420--------
Intrinsic Value_5Y_min---1.866--------
Net Profit Margin---2.160-2.929+36%-3.692+71%-3.143+46%-3.143+46%
Operating Margin---1.734-1.786+3%-2.965+71%-2.700+56%-2.700+56%
Operating Ratio--2.8262.705+4%4.195-33%3.798-26%3.798-26%
Pb Ratio0.956-7%1.0241.071-4%-+100%0.252+306%0.252+306%
Pe Ratio-6.403+7%-6.857-7.685+12%--100%-1.808-74%-1.808-74%
Peg Ratio---8.419-9.290+10%---9.290+10%-9.290+10%
Price Per Share1.410-7%1.5101.938-22%-+100%0.456+231%0.456+231%
Price To Total Gains Ratio-6.953+7%-7.446-5.535-26%---5.535-26%-5.535-26%
Profit Growth--0.8140.924-12%0.790+3%0.282+189%0.282+189%
Quick Ratio--12.2537.265+69%0.383+3100%1.957+526%1.957+526%
Return On Assets---0.109-0.103-6%-0.245+124%-0.303+177%-0.303+177%
Return On Equity---0.149-0.143-4%-3.370+2157%-1.361+811%-1.361+811%
Revenue Growth--1.0121.191-15%1.357-25%1.216-17%1.216-17%
Total Gains Per Share---0.2030.347-158%0.005-4209%0.087-334%0.087-334%
Total Gains Per Share Growth--0.8186.653-88%0.848-4%2.524-68%2.524-68%
Usd Book Value--8218000.0009988750.000-18%638750.000+1187%2690352.941+205%2690352.941+205%
Usd Book Value Change Per Share---0.2030.347-158%0.005-4209%0.087-334%0.087-334%
Usd Book Value Per Share--1.4751.793-18%0.115+1187%0.483+205%0.483+205%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.220-0.257+17%-0.150-32%-0.146-34%-0.146-34%
Usd Free Cash Flow---905000.000-876750.000-3%-632250.000-30%-571529.412-37%-571529.412-37%
Usd Free Cash Flow Per Share---0.162-0.157-3%-0.113-30%-0.103-37%-0.103-37%
Usd Free Cash Flow To Equity Per Share---0.4280.210-304%0.117-464%0.077-657%0.077-657%
Usd Price Per Share1.410-7%1.5101.938-22%-+100%0.456+231%0.456+231%
Usd Profit---1227000.000-1434250.000+17%-838250.000-32%-811588.235-34%-811588.235-34%
Usd Revenue--568000.000514500.000+10%280000.000+103%339000.000+68%339000.000+68%
Usd Total Gains Per Share---0.2030.347-158%0.005-4209%0.087-334%0.087-334%
 EOD+3 -2MRQTTM+12 -27YOY+16 -205Y+17 -2210Y+17 -22

4.2. Fundamental Score

Let's check the fundamental score of Nexgel Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-6.403
Price to Book Ratio (EOD)Between0-10.956
Net Profit Margin (MRQ)Greater than0-2.160
Operating Margin (MRQ)Greater than0-1.734
Quick Ratio (MRQ)Greater than112.253
Current Ratio (MRQ)Greater than17.457
Debt to Asset Ratio (MRQ)Less than10.268
Debt to Equity Ratio (MRQ)Less than10.367
Return on Equity (MRQ)Greater than0.15-0.149
Return on Assets (MRQ)Greater than0.05-0.109
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Nexgel Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.410
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2022-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets11,234
Total Liabilities3,016
Total Stockholder Equity8,218
 As reported
Total Liabilities 3,016
Total Stockholder Equity+ 8,218
Total Assets = 11,234

Assets

Total Assets11,234
Total Current Assets8,315
Long-term Assets8,315
Total Current Assets
Cash And Cash Equivalents 1,427
Short-term Investments 5,985
Net Receivables 265
Inventory 399
Other Current Assets 239
Total Current Assets  (as reported)8,315
Total Current Assets  (calculated)8,315
+/-0
Long-term Assets
Property Plant Equipment 2,522
Goodwill 311
Intangible Assets 23
Other Assets 63
Long-term Assets  (as reported)2,919
Long-term Assets  (calculated)2,919
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,115
Long-term Liabilities1,901
Total Stockholder Equity8,218
Total Current Liabilities
Short-term Debt 221
Short Long Term Debt 14
Accounts payable 358
Other Current Liabilities 536
Total Current Liabilities  (as reported)1,115
Total Current Liabilities  (calculated)1,129
+/- 14
Long-term Liabilities
Long term Debt 269
Capital Lease Obligations Min Short Term Debt1,618
Long-term Liabilities  (as reported)1,901
Long-term Liabilities  (calculated)1,887
+/- 14
Total Stockholder Equity
Common Stock6
Retained Earnings -10,910
Other Stockholders Equity 19,122
Total Stockholder Equity (as reported)8,218
Total Stockholder Equity (calculated)8,218
+/-0
Other
Capital Stock6
Cash and Short Term Investments 7,412
Common Stock Shares Outstanding 5,572
Liabilities and Stockholders Equity 11,234
Net Debt 695
Net Invested Capital 8,501
Net Tangible Assets 7,884
Net Working Capital 7,200
Short Long Term Debt Total 2,122



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
> Total Assets 
894
0
1,153
739
0
1,808
1,629
1,955
2,259
2,204
2,257
3,426
0
4,941
16,983
14,080
13,771
11,234
11,23413,77114,08016,9834,94103,4262,2572,2042,2591,9551,6291,80807391,1530894
   > Total Current Assets 
199
0
696
361
0
499
361
614
514
461
363
1,450
909
1,810
13,927
11,099
10,785
8,315
8,31510,78511,09913,9271,8109091,45036346151461436149903616960199
       Cash And Cash Equivalents 
0
0
0
0
0
186
88
220
233
157
32
1,070
0
1,255
13,350
10,520
4,420
1,427
1,4274,42010,52013,3501,25501,070321572332208818600000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,371
5,985
5,9855,3710000000000000000
       Net Receivables 
99
0
172
34
0
72
134
210
97
118
73
96
219
193
209
132
300
265
26530013220919321996731189721013472034172099
       Inventory 
93
0
183
101
0
140
113
124
168
157
233
252
226
261
291
280
381
399
3993812802912612262522331571681241131400101183093
       Other Current Assets 
7
0
341
226
0
101
26
60
16
29
25
32
0
101
77
167
313
239
239313167771010322529166026101022634107
   > Long-term Assets 
695
0
457
378
0
1,309
1,268
1,341
1,745
1,743
1,894
1,976
0
3,131
3,056
2,981
2,986
2,919
2,9192,9862,9813,0563,13101,9761,8941,7431,7451,3411,2681,30903784570695
       Property Plant Equipment 
522
0
279
200
0
1,131
1,090
1,163
1,200
1,237
1,358
1,571
2,790
2,720
2,649
2,577
2,536
2,522
2,5222,5362,5772,6492,7202,7901,5711,3581,2371,2001,1631,0901,13102002790522
       Goodwill 
0
0
0
0
0
0
0
0
367
0
311
311
0
311
311
311
311
311
3113113113113110311311036700000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
328
47
44
0
37
33
30
26
23
232630333704447328000000000
       Long-term Assets Other 
173
0
178
178
0
178
178
178
178
178
178
50
0
63
63
63
113
63
6311363636305017817817817817817801781780173
> Total Liabilities 
269
0
614
458
0
1,867
1,441
1,399
1,818
1,830
2,186
2,426
0
4,457
4,898
3,776
4,423
3,016
3,0164,4233,7764,8984,45702,4262,1861,8301,8181,3991,4411,86704586140269
   > Total Current Liabilities 
210
0
561
407
0
1,098
705
716
903
939
1,332
1,602
1,770
2,409
2,888
1,804
2,491
1,115
1,1152,4911,8042,8882,4091,7701,6021,3329399037167051,09804075610210
       Short-term Debt 
0
0
0
0
0
207
207
207
354
354
423
584
0
1,503
2,254
1,101
1,447
221
2211,4471,1012,2541,503058442335435420720720700000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
216
377
0
1,296
2,047
908
1,258
14
141,2589082,0471,29603772160000000000
       Accounts payable 
63
0
305
157
0
496
479
383
416
434
658
644
592
513
254
183
522
358
3585221832545135926446584344163834794960157305063
       Other Current Liabilities 
147
0
256
250
0
395
19
126
133
151
213
336
268
393
380
520
522
536
5365225203803932683362131511331261939502502560147
   > Long-term Liabilities 
59
0
53
51
0
769
736
683
915
891
854
824
0
2,048
2,010
1,972
1,932
1,901
1,9011,9321,9722,0102,048082485489191568373676905153059
> Total Stockholder Equity
625
0
539
281
0
-59
188
556
441
374
71
1,000
0
484
12,085
10,304
9,348
8,218
8,2189,34810,30412,08548401,00071374441556188-5902815390625
   Common Stock
625
0
539
281
0
5
8
73
82
89
99
103
104
104
6
6
6
6
6666104104103998982738502815390625
   Retained Earnings Total Equity000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000
   Capital Surplus 000000000000000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
-64
106
1,229
1,635
2,106
2,474
4,103
0
5,553
18,891
18,946
19,025
19,122
19,12219,02518,94618,8915,55304,1032,4742,1061,6351,229106-6400000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue1,551
Cost of Revenue-1,542
Gross Profit99
 
Operating Income (+$)
Gross Profit9
Operating Expense-2,579
Operating Income-2,570-2,570
 
Operating Expense (+$)
Research Development31
Selling General Administrative2,535
Selling And Marketing Expenses-
Operating Expense2,5792,566
 
Net Interest Income (+$)
Interest Income-
Interest Expense-1,998
Net Interest Income-1,998-1,998
 
Pretax Income (+$)
Operating Income-2,570
Net Interest Income-1,998
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-4,310-830
EBIT - interestExpense = -4,310
-4,310
-2,312
Interest Expense1,998
Earnings Before Interest and Taxes (ebit)-2,312-2,312
Earnings Before Interest and Taxes (ebitda)-2,199
 
After tax Income (+$)
Income Before Tax-4,310
Tax Provision--
Net Income From Continuing Ops-4,310-4,310
Net Income-4,310
Net Income Applicable To Common Shares-4,310
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses4,121
Total Other Income/Expenses Net-1,7401,998
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
ICT.AU
3 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ICT.AU.

ICT.AU Daily Candlestick Chart
CEI.PSE
3 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CEI.PSE.

CEI.PSE Daily Candlestick Chart
VUL.PSE
26 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of VUL.PSE.

VUL.PSE Daily Candlestick Chart
PHA.PSE
27 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of PHA.PSE.

PHA.PSE Daily Candlestick Chart
CIP.AU
28 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CIP.AU.

CIP.AU Daily Candlestick Chart
CGC.AU
28 minutes ago

I found you a Golden Cross on the daily chart of CGC.AU.

CGC.AU Daily Candlestick Chart
CCP.AU
29 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CCP.AU.

CCP.AU Daily Candlestick Chart
JGS.PSE
29 minutes ago

I found you a Golden Cross on the daily chart of JGS.PSE.

JGS.PSE Daily Candlestick Chart
EW.PSE
31 minutes ago

I found you a Golden Cross on the daily chart of EW.PSE.

EW.PSE Daily Candlestick Chart
CHP.PSE
31 minutes ago

I found you a Golden Cross on the daily chart of CHP.PSE.

CHP.PSE Daily Candlestick Chart
BLG.AU
33 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of BLG.AU.

BLG.AU Daily Candlestick Chart
BAS.AU
35 minutes ago

I found you a RSI Bullish Hidden Divergence on the daily chart of BAS.AU.

BAS.AU Daily Candlestick Chart
ATA.AU
39 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ATA.AU.

ATA.AU Daily Candlestick Chart
ARR.AU
39 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ARR.AU.

ARR.AU Daily Candlestick Chart
ARG.AU
39 minutes ago

I found you a Golden Cross on the daily chart of ARG.AU.

ARG.AU Daily Candlestick Chart
AQC.AU
39 minutes ago

I found you a Death Cross on the daily chart of AQC.AU.

AQC.AU Daily Candlestick Chart
AMX.AU
40 minutes ago

I found you a RSI Bearish Reversal Divergence on the daily chart of AMX.AU.

AMX.AU Daily Candlestick Chart
AKP.AU
42 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of AKP.AU.

AKP.AU Daily Candlestick Chart
ADH.AU
45 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ADH.AU.

ADH.AU Daily Candlestick Chart
ABP.AU
45 minutes ago

I found you a Golden Cross on the daily chart of ABP.AU.

ABP.AU Daily Candlestick Chart
WAM.AU
53 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of WAM.AU.

WAM.AU Daily Candlestick Chart
VR8.AU
53 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VR8.AU.

VR8.AU Daily Candlestick Chart
VGE.AU
55 minutes ago

I found you a Golden Cross on the daily chart of VGE.AU.

VGE.AU Daily Candlestick Chart